Answers are grounded in this paper and cite their sources.
Nephrotoxicity was assessed in 173 critically ill patients receiving intravenous colistin or polymyxin B; it occurred in 60.4% and 41.8%, respectively. Further investigation is necessary to elucidate the reason for the difference in nephrotoxicity observed between the groups and to assess the impact of severity of illness and dosing/administration.
No takes yet. Share an insight, caveat, or question.
Akajagbor et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: